MTHFR and laryngotracheoesophageal cleft: al [73] showed that MTHFR heterozygotes yield better clinical benefit (P =.03) after platinum based chemotherapy, however, overall survival and progression-free survival of LC patients do not differ regarding MTHFR polymorphic variants.